Strix
26.1K

CVE-2021-26726

HIGHCVSS 8.8/10EPSS 1.10%

Last modified

CVE-2021-26726 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.. EPSS estimates a 1.10% chance of exploitation in the next 30 days.

Description

A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
1.10%

61.6th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
ValmetDna>= 2012, <= 2021

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2021-26726?
A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.
How severe is CVE-2021-26726?
CVE-2021-26726 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 1.10% probability of exploitation in the next 30 days.
How do I fix CVE-2021-26726?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2021-26726?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST